- Home
- PRTA vs PSNYW Comparison
PRTA vs PSNYW Comparison
Compare PRTA & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- PSNYW
- Stock Information
- Founded
- PRTA 2012
- PSNYW 2017
- Country
- PRTA Ireland
- PSNYW Sweden
- Employees
- PRTA N/A
- PSNYW 2547
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- PSNYW Auto Manufacturing
- Sector
- PRTA Health Care
- PSNYW Consumer Discretionary
- Exchange
- PRTA Nasdaq
- PSNYW Nasdaq
- Market Cap
- PRTA 472.1M
- PSNYW 625.2M
- IPO Year
- PRTA N/A
- PSNYW N/A
- Fundamental
- Price
- PRTA $8.20
- PSNYW $0.30
- Analyst Decision
- PRTA Buy
- PSNYW
- Analyst Count
- PRTA 10
- PSNYW 0
- Target Price
- PRTA $14.86
- PSNYW N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- PSNYW 43.4K
- Earning Date
- PRTA 08-04-2025
- PSNYW 03-06-2025
- Dividend Yield
- PRTA N/A
- PSNYW N/A
- EPS Growth
- PRTA N/A
- PSNYW N/A
- EPS
- PRTA N/A
- PSNYW N/A
- Revenue
- PRTA $10,341,000.00
- PSNYW $2,034,261,000.00
- Revenue This Year
- PRTA N/A
- PSNYW N/A
- Revenue Next Year
- PRTA $389.77
- PSNYW $79.49
- P/E Ratio
- PRTA N/A
- PSNYW N/A
- Revenue Growth
- PRTA N/A
- PSNYW N/A
- 52 Week Low
- PRTA $4.32
- PSNYW $0.09
- 52 Week High
- PRTA $22.83
- PSNYW $0.61
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- PSNYW 56.04
- Support Level
- PRTA $8.05
- PSNYW $0.16
- Resistance Level
- PRTA $8.73
- PSNYW $0.80
- Average True Range (ATR)
- PRTA 0.38
- PSNYW 0.06
- MACD
- PRTA -0.05
- PSNYW 0.02
- Stochastic Oscillator
- PRTA 47.62
- PSNYW 15.62
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.